SCHEMBL22888271

SCHEMBL22888271

CN1C(=O)C(NC=O)CCn2nc(C3CC3)cc21

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 17/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22888661 0.86 RIPK1 (0.50) RIPK1
SCHEMBL22888314 0.85 RIPK1 (0.52) RIPK1
SCHEMBL19655837 0.85 RIPK1 (0.52) RIPK1
SCHEMBL19658983 0.80 RIPK1 (0.45) RIPK1
SCHEMBL18367465 0.79 RIPK1 (0.44) RIPK1
SCHEMBL18366331 0.79 RIPK1 (0.44) RIPK1
SCHEMBL18366332 0.79 RIPK1 (0.44) RIPK1
SCHEMBL18365806 0.79 RIPK1 (0.44) RIPK1
SCHEMBL18366173 0.79 RIPK1 (0.44) RIPK1
SCHEMBL22887818 0.78 RIPK1 (0.46) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3760625-A1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2021-01-06 EP disclosed